GREENWICH BIOSCIENCES
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

GREENWICH BIOSCIENCES Trademark

Serial Number: 99058243 • Registration: 8028682

GREENWICH BIOSCIENCES is a trademark filed by JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED on February 26, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

JAZZ PHARMACEUTICALS OPERATIONS UK LIMITED (14 trademarks)

BUILDING 730 KENT SCIENCE PARK
SITTINGBOURNE, KENT ME9 8AG , GB

Entity Type: 24

Trademark Details

Filing Date

February 26, 2025

Registration Date

November 18, 2025

Published for Opposition

September 30, 2025

Goods & Services

Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, cancer symptoms, multiple sclerosis (MS), spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalised epilepsy with febrile seizures plus (GEFS positive), dup 15, and Doose syndrome, and for use in oncology; pharmaceutical preparations and substances for the treatment of bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, LennoxGastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis; pharmaceutical preparations and substances for the treatment of metabolic disorders, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness and for the use in oncology; pharmaceutical preparations and substances for the treatment of diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism; herbs for medicinal purposes; medicinal herbs; medicinal infusions for treating pain, neuropathic pain, cancer pain, peri-operative pain, cancer symptoms, multiple sclerosis, spasticity, MS spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICEGTC), generalised epilepsy with febrile seizures plus (GEFS positive), dup 15, and Doose syndrome and for use in oncology; medicinal infusions for treating bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, LennoxGastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis; medicinal infusions for treating metabolic disorders, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxicischemic encephalopathy, neonatal hypoxic encephalopathy, stroke, motion sickness and chemically induced sickness and for use in oncology; medicinal infusions for treating diabetes, type II diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse, autism; pure extracts of medicinal plants and herbs other than essential oils for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 30, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 30, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 24, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 2, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 29, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 8, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 8, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 8, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 31, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 26, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2025 NWOS
NEW APPLICATION ENTERED
Feb 26, 2025 NWAP